Medline reports Q1 adjusted EPS 33c, consensus 29c

Reports Q1 revenue $7.35B, consensus $7.16B. “We started 2026 with strong momentum-growing with our existing customers, executing implementations at scale and winning new customers,” said Jim Boyle, chief executive officer of Medline (MDLN). “This performance gives us confidence to raise our full year Organic Sales guidance while continuing disciplined investments in our people, infrastructure and capabilities to support our strong customer demand and position Medline for sustained growth.”